Colony Group LLC Novartis Ag Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Colony Group LLC holds 7,121 shares of NVS stock, worth $787,297. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,121

Previous 7,489 4.91%

Holding current value

$787,297

Previous $756,000 4.1%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $34,860 - $38,687	-368 Reduced 4.91%	7,121 $725,000
Q2 2023 Aug 15, 2023	SELL	$92.52 - $104.91 $7,864 - $8,917	-85 Reduced 1.12%	7,489 $756,000
Q1 2023 May 16, 2023	SELL	$80.03 - $92.81 $113,802 - $131,975	-1,422 Reduced 15.81%	7,574 $697,000
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $135,612 - $166,073	1,795 Added 24.93%	8,996 $816,000
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $344,474 - $402,879	4,617 Added 178.68%	7,201 $547,000
Q2 2022 Aug 16, 2022	SELL	$80.52 - $93.75 $383,919 - $447,000	-4,768 Reduced 64.85%	2,584 $218,000
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $9,452 - $10,693	118 Added 1.63%	7,352 $645,000
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $159 - $176	2 Added 0.03%	7,234 $633,000
Q3 2021 Nov 17, 2021	SELL	$81.78 - $95.14 $92,084 - $107,127	-1,126 Reduced 13.47%	7,232 $591,000
Q2 2021 Aug 18, 2021	SELL	$85.24 - $94.15 $189,744 - $209,577	-2,226 Reduced 21.03%	8,358 $763,000
Q1 2021 May 21, 2021	BUY	$83.5 - $98.47 $160,737 - $189,554	1,925 Added 22.23%	10,584 $905,000
Q4 2020 Feb 16, 2021	SELL	$78.07 - $94.43 $146,225 - $176,867	-1,873 Reduced 17.78%	8,659 $818,000
Q3 2020 Nov 17, 2020	BUY	$82.14 - $91.0 $21,767 - $24,115	265 Added 2.58%	10,532 $916,000
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $28,811 - $32,431	-356 Reduced 3.35%	10,267 $897,000
Q1 2020 May 18, 2020	BUY	$70.67 - $99.01 $105,863 - $148,316	1,498 Added 16.42%	10,623 $876,000
Q4 2019 Feb 18, 2020	SELL	$84.35 - $95.37 $90,929 - $102,808	-1,078 Reduced 10.57%	9,125 $864,000
Q3 2019 Nov 26, 2019	BUY	$85.54 - $94.26 $6,928 - $7,635	81 Added 0.8%	10,203 $887,000
Q2 2019 Aug 19, 2019	BUY	$75.4 - $92.8 $376,396 - $463,257	4,992 Added 97.31%	10,122 $924,000
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $144,765 - $165,580	1,922 Added 59.91%	5,130 $493,000
Q4 2018 Feb 15, 2019	SELL	$73.66 - $82.02 $9,133 - $10,170	-124 Reduced 3.72%	3,208 $275,000
Q3 2018 Nov 14, 2018	BUY	$66.94 - $77.43 $11,714 - $13,550	175 Added 5.54%	3,332 $287,000
Q2 2018 Aug 15, 2018	SELL	$64.91 - $73.36 $7,789 - $8,803	-120 Reduced 3.66%	3,157 $238,000
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $295,567 - $353,345	-4,199 Reduced 56.17%	3,277 $265,000
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $350,294 - $376,010	4,843 Added 183.93%	7,476 $628,000
Q3 2017 Nov 15, 2017	BUY	$74.14 - $77.27 $195,210 - $203,451	2,633	2,633 $226,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.55M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $238B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account